menu
    • menu

    Company profile for Celcuity

    NEW Drugs in Dev: 1
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Celcuity was founded in 2012 by Brian Sullivan and Lance Laing, PhD, to develop a better way to diagnose and treat the cellular abnormalities that drive tumor growth. Our team of drug development scientists, biochemists, molecular biologists, and diagnostics experts are advancing new targeted therapies for cancer using an integrated therapeutic and companion diagnostic strategy that leverages our CELsignia platform. This allow...
    Celcuity was founded in 2012 by Brian Sullivan and Lance Laing, PhD, to develop a better way to diagnose and treat the cellular abnormalities that drive tumor growth. Our team of drug development scientists, biochemists, molecular biologists, and diagnostics experts are advancing new targeted therapies for cancer using an integrated therapeutic and companion diagnostic strategy that leverages our CELsignia platform. This allows Celcuity to discover new cancer sub-types molecular diagnostics cannot detect.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CelcuityUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    16305 – 36th Avenue North Suite 100 Minneapolis, MN 55446
    Telephone
    Telephone
    763-473-0341
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.celcuity.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/celcuity/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Celcuity Reports 2025 Financial Results And Corporate Update
    Celcuity Reports 2025 Financial Results And Corporate Update

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262558/0/en/Celcuity-Inc-Reports-Release-of-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    Celcuity Schedules Q4 2025 & FY Earnings Call
    Celcuity Schedules Q4 2025 & FY Earnings Call

    18 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/18/3258100/0/en/Celcuity-Schedules-Release-of-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Webcast-Conference-Call.html

    GLOBENEWSWIRE
    18 Mar 2026
    Share Share
    Celcuity To Participate In Upcoming Investor Conferences
    Celcuity To Participate In Upcoming Investor Conferences

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3244956/0/en/Celcuity-To-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share
    Celcuity Appoints Charles Romp To Its Board Of Directors
    Celcuity Appoints Charles Romp To Its Board Of Directors

    12 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/12/3237672/0/en/Celcuity-Appoints-Charles-Romp-to-its-Board-of-Directors.html

    GLOBENEWSWIRE
    12 Feb 2026
    Share Share
    Celcuity To Present At Guggenheim Biotech Summit 2026
    Celcuity To Present At Guggenheim Biotech Summit 2026

    04 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/04/3231917/0/en/Celcuity-to-Present-at-Upcoming-Guggenheim-Emerging-Outlook-Biotech-Summit-2026.html

    GLOBENEWSWIRE
    04 Feb 2026
    Share Share
    FDA Accepts Celcuity's Gedatolisib for HR+/HER2- PIK3CA-WT Cancer
    FDA Accepts Celcuity's Gedatolisib for HR+/HER2- PIK3CA-WT Cancer

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3221601/0/en/Celcuity-Announces-FDA-Acceptance-of-New-Drug-Application-for-Gedatolisib-in-HR-HER2-PIK3CA-Wild-Type-Advanced-Breast-Cancer.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Contact Celcuity and get a quotation

    Celcuity is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Gedatolisib bulk offered by Celcuity

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search